First Time Loading...

Nephros Inc
NASDAQ:NEPH

Watchlist Manager
Nephros Inc Logo
Nephros Inc
NASDAQ:NEPH
Watchlist
Price: 2.23 USD 0.45% Market Closed
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

NEPH Price Targets Summary
Nephros Inc

Wall Street analysts forecast NEPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NEPH is 4.85 USD with a low forecast of 4.55 USD and a high forecast of 5.25 USD.

NEPH Lowest Forecast
Wall Street Target
4.55 USD
104% Upside
NEPH Average Forecast
Wall Street Target
4.85 USD
117% Upside
NEPH Highest Forecast
Wall Street Target
5.25 USD
135% Upside
Lowest
Price Target
4.55 USD
104% Upside
Average
Price Target
4.85 USD
117% Upside
Highest
Price Target
5.25 USD
135% Upside
Nephros Inc Competitors:
Price Targets
Z
002032
Zhejiang Supor Co Ltd
4% Upside
301187
Suzhou Alton Electrical & Mechanical Industry Co Ltd
24% Upside
7965
Zojirushi Corp
1% Downside
000651
Gree Electric Appliances Inc of Zhuhai
6% Upside
Z
002032
Zhejiang Supor Co Ltd
4% Upside
301187
Suzhou Alton Electrical & Mechanical Industry Co Ltd
24% Upside
7965
Zojirushi Corp
1% Downside
000651
Gree Electric Appliances Inc of Zhuhai
6% Upside
SYMPHONY
Symphony Ltd
6% Upside
Q
QEPC
QEP Co Inc
66% Downside
T
1614
Taiwan Sanyo Electric Co Ltd
7% Upside
002242
Joyoung Co Ltd
26% Upside

Revenue
Forecast

Revenue Estimate
Nephros Inc

For the last 8 years the compound annual growth rate for Nephros Inc's revenue is 28%. The projected CAGR for the next 2 years is 16%.

28%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Nephros Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Nephros Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

See Also

Summary
NEPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
NEPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NEPH stock valuation using valuation multiples.
Wall Street Estimates
NEPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NEPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NEPH's stock price target?
Price Target
4.85 USD

According to Wall Street analysts, the average 1-year price target for NEPH is 4.85 USD with a low forecast of 4.55 USD and a high forecast of 5.25 USD.

What is Nephros Inc's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Nephros Inc's revenue is 28%. The projected CAGR for the next 2 years is 16%.

ALPHA SPREAD
Join more than 133,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.